Inhibitory effects of anthocyanins on secretion of helicobacter pylori CagA and VacA toxins

International Journal of Medical Sciences

Volumn 9, Issue 10, 2012, Pages 838-842

  Kim, Sa Hyun ^a,b   Park, Min ^a   Woo, Hyunjun ^a   Tharmalingam, Nagendran ^a   Lee, Gyusang ^a   Rhee, Ki Jong ^a   Eom, Yong Bin ^c   Han, Sang Ik ^d   Seo, Woo Duck ^d   Kim, Jong Bae ^a  

^a Yonsei University Wonju   (South Korea)

^b Semyung University   (South Korea)

^c Korea Nazarene University   (South Korea)

^d National Institute of Animal Science   (South Korea)

Author keywords

Anthocyanin; CagA; Cyanidin 3 O glucoside; Helicobacter pylori; SecA; VacA

Indexed keywords

ANTHOCYANIN; CAGA PROTEIN; CYANIDIN 3 GLUCOSIDE; MALVIDIN 3 O GLUCOSIDE; PELARGONIDIN 3 O GLUCOSIDE; PEONIDIN3 O GLUCOSIDE; PROTEIN SECA; UNCLASSIFIED DRUG; VACUOLATING TOXIN;

ARTICLE; BACTERIUM CULTURE; BIOACCUMULATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; GENE TRANSLOCATION; HELICOBACTER PYLORI; NONHUMAN; PROTEIN EXPRESSION; TOXIN SECRETION; TOXIN SYNTHESIS; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ANTHOCYANIN; CAGA; CYANIDIN 3-O-GLUCOSIDE.; HELICOBACTER PYLORI; SECA; VACA;

ANTHOCYANINS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; GLUCOSIDES; HELICOBACTER PYLORI; HUMANS;

EID: 84869009107     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.5094     Document Type: Article

References (26)

1. Wiedemann T, Loell E, Mueller S, et al. Helicobacter pylori cag-Pathogenicity island-dependent early immunological response triggers later precancerous gastric changes in Mongolian gerbils. PLoS One. 2009; 4(3):e4754.
2. Cover TL, and Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology. 2009; 136(6):1863-1873.
3. Suerbaum S, and Michetti P. Helicobacter pylori infection. N Engl J Med. 2002; 347(15):1175-1186.
4. Crabtree JE, Xiang Z, Lindley IJD, et al. Induction of interleukin-8 secretion from gastric epithelial cells by a cagA negative isogenic mutant of Helicobacter pylori. J Clin Pathol. 1995; 48(10):967-969.
5. Covacci A, Telford JL, Del Giudice G, et al. Helicobacter pylori virulence and genetic geography. Science. 1999; 284(5418):1328-1333.
6. Hatakeyama M. Helicobacter pylori CagA-a potential bacterial oncoprotein that functionally mimics the mammalian Gab family of adaptor proteins. Microbes Infect. 2003; 5(2):143-150.
7. Cover TL, and Blanke SR. Helicobacter pylori VacA, a paradigm for toxin Multifunctionality. Nat Rev Microbiol. 2005; 3(4):320-332.
8. Heber D. Vegetables, fruits and phytoestrogens in the prevention of diseases. J Postgrad Med. 2004; 50(2):145-149.
9. Juranić Z, Zizak Z. Biological activities of berries: from antioxidant capacity to anti-cancer effects. Biofactors. 2005; 23(4):207-211.
10. Burger O, Ofek I, Tabak M, et al. A high molecular mass constituent of cranberry juice inhibits Helicobacter pylori adhesion to human gastric mucus. FEMS Immunol Med Microbiol. 2000; 29(4):295-301.
11. Burger O, Weiss E, Sharon N, et al. Inhibition of Helicobacter pylori adhesion to human gastric mucus by a high-molecular-weight constituent of cranberry juice. Crit Rev Food Sci Nutr. 2002; 42 (3 Suppl):279-284.
12. Neto CC. Cranberry and its phytochemicals: a review of in vitro anticancer studies. J Nutr. 2007; 137 (1 Suppl):186S-193S.
13. Zafra-Stone S, Yasmin T, Bagchi M, et al. Berry anthocyanins as novel antioxidants in human health and disease prevention. Mol Nutr Food Res. 2007; 51(6):675-683.
14. Abdel-Aal el-SM, Young JC, Rabalski I. Anthocyanin composition in black, blue, pink, purple, and red cereal grains. J Agric Food Chem. 2006; 54(13):4696-4704.
15. Fiocca R, Necchi V, Sommi P, et al. Release of Helicobacter pylori vacuolating cytotoxin by both a specific secretion pathway and budding of outer membrane vesicle uptake of released toxin and vesicles by gastric epithelium. J Pathol. 1999; 188(2):220-226.
16. Feltcher ME, Braunstein M. Emerging themes in SecA2-mediated protein export. Nat Rev Microbiol. 2012; 10:779-789.
17. Shaffer CL, Gaddy JA, Loh JT, et al. Helicobacter pylori exploits a unique repertoire of type IV secretion system components for pilus assembly at the bacteria-host cell interface. PLoS Pathog. 2011; 7(9):e1002237.
18. Fronzes R, Christie PJ, Waksman G. The structural biology of type IV secretion systems. Nat Rev Microbiol. 2009; 7(10):703-714.
19. Delahay RM, and Rugge M. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2012; Suppl 1:9-15.
20. Ripoll-Rozada J, Peña A, Rivas S, et al. Regulation of the type IV secretion ATPase TrwD by magnesium: implications for the catalytic mechanism of the secretion ATPase superfamily. J Biol Chem. 2012; 287(21):17408-17414.
21. Molnar B, Galamb O, Sipos F, et al. Molecular pathogenesis of Helicobacter pylori infection: The role of bacterial virulence factors. Dig Dis. 2010; 28(4-5):604-608.
22. Backert S, Clyne M, Tegtmeyer N, et al. Molecular mechanisms of gastric epithelial cell adhesion and injection of CagA by Helicobacter pylori. Cell Commun Signal. 2011; 9(28):1-11.
23. Andrzejewska J, Lee SK, Olbermann P, et al. Characterization of the pilin ortholog of the Helicobacter pylori type IV cag pathogenicity apparatus, a surface-associated protein expressed during infection. J Bacteriol. 2006; 188(16):5865-5877.
24. Pham KT, Weiss E, Jiménez Soto LF, et al. CagI is an essential component of the Helicobacter pylori Cag type IV secretion system and forms a complex with CagL. PLoS ONE. 2012; 7(4):e35341.
25. Boonjakuakul JK, Canfield DR, Solnick JV. Comparison of Helicobacter pylori virulence gene expression in vitro and in the Rhesus Macaque. Infect Immun. 2005; 73(8):4895-4904.
26. Kwon DH, Osato MS, Graham DY, et al. Quantitative RT-PCR analysis of multiple genes encoding putative metronidazole nitroreductases from Helicobacter pylori. Int J Antimicrob Agents. 2000; 15(1):31-36.